Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06189066 · ClinicalTrials.gov registry record · NA
Long COVID Ultrasound Trial
A NA study of Long COVID, sponsored by SecondWave Systems.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06189066: Completed NA study of Long COVID, sponsored by SecondWave Systems.
NCT06189066 is a NA study of Long COVID that has completed, run by SecondWave Systems. The registered enrollment target is 15 participants, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06189066, a NA study of Long COVID, has completed, sponsored by SecondWave Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The research objective is to assess the safety and potential efficacy of spleen ultrasound stimulation as an intervention for Long COVID in a pilot study. Specific Aims include: * Measure Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stimulation. * Measure molecular correlates of Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stimulation. * Track adverse events throughout the study to assess safety of the ultrasound intervention.
Primary Outcome
ESWT is a standardized, externally controlled, constant-paced walking test for the assessment of endurance capacity. Improvement in this outcome will be determined by an increase of distance walked and/or increase in time walked before failure to maintain the controlled walking pace.
Conditions Studied
Interventions
- DEVICE Splenic Ultrasound
Study Locations (1)
Minnesota
- University of Minnesota - Phillips-Wangensteen Building - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-01-03 |
| Est. Completion | 2025-07-24 |
| Phase | NA |
What the finished NCT06189066 record still lists
NCT06189066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Splenic Ultrasound is the first listed.
NCT06189066 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06189066 about?
NCT06189066 is a clinical study titled "Long COVID Ultrasound Trial". The research objective is to assess the safety and potential efficacy of spleen ultrasound stimulation as an intervention for Long COVID in a pilot study. Specific Aims include: * Measure Long COVID disease activity before, during and after an 8-week course of spleen-directed daily ultrasound stim...
What is the current status of trial NCT06189066?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2024-01-03. Estimated completion is 2025-07-24.
What conditions does trial NCT06189066 study?
This clinical trial studies the following conditions: Long COVID.
What interventions are being tested in trial NCT06189066?
The interventions under investigation include: Splenic Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT06189066?
This trial is sponsored by SecondWave Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06189066 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06189066's enrollment target sits among peer trials
15 50th of 50 higher than 1 of 50 other Long COVID trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Water-based Activity to Enhance Recovery in Long COVID-19
RECRUITING · NA
-
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Sauna for Long Covid
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI